Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cuprina Holdings (Cayman) Limited (CUPR : NSDQ)

• Company Description    Cuprina Holdings Limited is a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector. Cuprina Holdings Limited is based in SINGAPORE. Number of Employees: 14

• Price / Volume Information    Yesterday's Closing Price: $0.40 Daily Weekly Monthly 20 Day Moving Average: 87,852 shares Shares Outstanding: 21.00 (millions) Market Capitalization: $8.40 (millions) Beta: 52 Week High: $9.50 52 Week Low: $0.38 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.45% -38.34% 12 Week -62.95% -63.55% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BLOCK 1090 LOWER DELTA ROAD 06-08 - SINGAPORE,U0 169201 SGP ph: 658-512-7275 fax: - None http://www.cuprina.com

• General Corporate Information    Officers David Quek Yong Qi - Chief Executive Officer Chan Tat Jing - Chief Financial Officer Baptista Carl Marc - Director Teo Peng Kwang - Director Chan Tat Jing - Director Peer Information Cuprina Holdings (Cayman) Limited (CORR.) Cuprina Holdings (Cayman) Limited (RSPI) Cuprina Holdings (Cayman) Limited (CGXP) Cuprina Holdings (Cayman) Limited (BGEN) Cuprina Holdings (Cayman) Limited (GTBP) Cuprina Holdings (Cayman) Limited (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G2592E102 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 05/13/26 Share - Related Items Shares Outstanding: 21.00 Most Recent Split Date: (:1) Beta: Market Capitalization: $8.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.40 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - - 06/30/25 - - Current Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 3.58 Quick Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - - Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - 0.29 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.02 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 1.84

Powered by Zacks Investment Research ©